1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLocal Innovation Partnerships Fund (LIPF) is sponsored by Innovate UK (via West Midlands Combined Authority). Supports innovative businesses in the West Midlands to commercialise and scale new products and services in health and life sciences, advanced manufacturing, and creative technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Local Innovation Partnerships Fund Local Innovation Partnerships Fund (LIPF) Funding and support to commercialise at scale. The Local Innovation Partnerships Fund (LIPF) provides funding and support to commercialise at scale for companies developing new products and services in creative industries, advanced manufacturing, and health and life sciences.
It’s open to innovative businesses in the West Midlands Combined Authority (WMCA) area with strong scale-up potential. If you're based outside that geography see FAQs below.
To be eligible, your organisation should be developing, commercialising or scaling technology in one of the three priority areas: Clinical Commercial Catalyst for Health and Life Sciences CISL for Creative and Immersive Technologies FORGE for Advanced Manufacturing The primary purpose of this programme is to generate economic growth in the WMCA area.
We recognise that supply chains and technology partnerships can extend beyond administrative boundaries. We are therefore open to some activity taking place outside this area provided this is properly justified, and local economic benefit can be demonstrated.
More information on the projects There are three projects to apply for: Clinical Commercial Catalyst for Health & Life Sciences The Clinical Commercial Catalyst for Health and Life Sciences is a unified regional programme of support for high-potential local and global businesses to trial, enhance and scale their innovations through cutting- edge clinical, commercial and academic R&D infrastructure, underpinned by demand-led flexible funding to drive regional impact.
Supported businesses will receive access to a range of support from industry experts, led by the University of Birmingham in partnership with Aston University, Birmingham City University, Coventry University, University of Warwick and University of Wolverhampton, as well as NHS teams, innovative business support organisations such as RESILIENCE Ltd, the Primary Care Accelerator and Medilink Midlands, delivering: Access to flexible funding and academic and clinical partners.
Skills training, investment readiness training, scale-up support and peer-to-peer mentoring. Increased regional, national and international profile and market access. Easier access to clinical trials and NHS testing environments.
Access to health data, patient populations, samples and diagnostics infrastructure. Access to specialist clean-room and near-patient biomanufacturing facilities. Support developing regulatory-ready evidence.
CreaTech Innovation Scale-Up Lab (CISL) CISL unifies the West Midlands CreaTech ecosystem, integrating screen and games innovation through R&D platforms, adoption labs and a scaling fund to accelerate SME growth, drive cross-sector spillovers, boost investment readiness and strengthen a nationally significant creative technology sector.
Supported businesses will receive highly tailored support from industry and innovation experts, public sector, and academia.
Led by the University of Warwick, working in partnership with Aston University, Birmingham City University, University of Birmingham, Coventry University and University of Wolverhampton, and supported by Digital Catapult and specialist regional and national agencies, WM CISL will deliver: Access to funding, investment readiness support, internationalisation support, and cutting-edge R&D facilities.
Opportunities for direct collaboration with major industry anchors such as BBC, Banijay, Sony, and Cisco. Tailored commercialisation and IP support, including specialist help with product development and market readiness. User-testing, access to shared facilities, virtual production, immersive tech, and cross-sector market access.
Cross-sector spillover opportunities, such as routes into Advanced Manufacturing and Health & Life Sciences markets. Networking & brokerage, including rapid introductions, cluster events, and ecosystem integration.
Future Oriented Regional Growth in Engineering (FORGE) FORGE is designed to help ambitious manufacturing businesses in the West Midlands accelerate growth through near-to-market R&D in future mobility and manufacturing for the clean energy transition.
Through the programme, businesses may access funding, specialist advanced manufacturing expertise, support to shape and de-risk a growth project, and connections to investment and scale-up opportunities. FORGE is intended to be practical/applied and business-led.
The starting point will be the company’s own growth opportunity, with the programme helping to identify the right support, partners and funding pathway to make that opportunity more achievable. FORGE delivery and partner team: Lead: WMG, University of Warwick.
Academic and Catapult Centre Partners: WMG, University of Warwick, University of Birmingham, Coventry University, University of Wolverhampton and Manufacturing Technology Centre (MTC). Industry partners: the Black Country Industrial Cluster (BCIC-WM), Midlands Aerospace Alliance (MAA) with support from WMCA and the WM Growth Company. Private Sector Anchors: JLR.
Public Sector partners: West Midlands Combined Authority (WMCA) and West Midlands Growth Company (WMGC). All projects must be business-led, giving companies the opportunity to work with partners to determine the most valuable combination of funding and R&D support to accelerate growth.
Delivered by WMG at the University of Warwick, the programme provides flexible support tailored to business needs, which may include grant funding, access to specialist resources, or a combination of both. Supported businesses can benefit from: Access to capital funding, with up to 50% of project investment funded and the remainder provided from the business’s own resources.
Funding for high-growth, near-to-market R&D projects in future mobility, advanced manufacturing, and the clean energy transition, including support for businesses adapting supply chains to compete in cleaner global markets.
Collaboration with world-leading advanced manufacturing and engineering expertise, facilities and innovation partners across the West Midlands ecosystem and, where appropriate, specialist academic facilities beyond the region. Tailored project planning and strategic roadmaps that align with commercial priorities and provide a clear, manageable pathway for growth.
Expert support to identify and de-risk technical, manufacturing, supply-chain and commercial barriers, helping businesses accelerate innovation and investment readiness. Assistance in strengthening value propositions, business cases and growth strategies to support sustainable scaling and long-term success.
Connections to investors, industry networks and supply-chain partners, creating opportunities for further investment, collaboration and market growth. Eligibility criteria and further details Before you submit your expression of interest, please ensure it aligns with the criteria below: 1. Your project must align to the aims of the Local Innovation Partnerships Fund projects.
2. The project must be business-led and should focus on near-to-market R&D that will have a transformational impact on the growth trajectory of your business. Projects can include more than one business.
3. Projects must be of £200k to £2m in size with a 50% industry match able to be provided (so £100k to £1m grants available). Industry match contribution is as per the UKRI definition of match funding (cash or in-kind).
Grants will be paid in arrears. 4. Up to 30% of grant value can be allocated to a research or technology organisation (RTO) such as a university, catapult centre, national scientific laboratory, science park, the West Midlands Growth Company, a local authority or combined authority, an NHS Trust, or another similar research partner organisation.
5. Your company must have a clear and strong value proposition with supporting evidence for their innovation. 6.
Your company should be based in the core WMCA area of the West Midlands, though this does not have to be their primary base. A company may also be based within the wider functional economic geography of the relevant innovation sector, where the company is able to demonstrate clear additional benefit to the economy of the WMCA area.
Extraordinary projects that fall outside this criteria can be considered, where a compelling case can be made in line with the aims and outcomes of the West Midlands Local Innovation Partnerships Fund. Further detailed conditions will be available following an initial assessment of your expression of interest form. Please see our FAQs below for further clarifications.
Complete this short form to express your interest in any of the three LIPF projects. Eligibility FAQs and clarifications Where should research and technology organisations be based? Research or technology organisations (RTOs) should generally be based in the WMCA area.
By exception, companies can choose to work with RTOs in the wider UK. A strong business justification will be needed in the EOI and full application form. Which local authorities make up the WMCA area?
WMCA (West Midlands Combined Authority) refers to the local authority areas of Coventry, Solihull, Birmingham, Sandwell, Dudley, Walsall and Wolverhampton. If you are based in the West Midlands region (wider functional economic geography of the relevant innovation sector), but not the WMCA area, you can still apply for this funding so long as you can demonstrate local economic benefit. What is the definition of the West Midlands region?
The West Midlands region is defined here . What is considered "clear additional benefit to the WMCA area"? Clear travel-to-work linkages, i.e. a significant number of the company employees live within the core WMCA area, and/or significant procurement, supply chain activities, or skills initiatives and/or genuine commitment to relocating to the WMCA area during the lifetime of the project.
Can I apply if I'm based outside of the West Midlands region? You can apply if you are in the UK but outside of the West Midlands region area but you must demonstrate commitment to relocating before the end of your project. The West Midlands Growth Company team will work with you to validate your interest and provide support to help you locate in the WMCA area.
What should a "clear and strong value proposition with supporting evidence for their innovation" include? Evidence of innovation and differentiation (IP, new formats, tech, content innovation, process innovation); an understanding of their total achievable market and serviceable obtainable market not just the total market; an understanding of the preferred first market opportunity.
The first market should be of sufficient size to support the commercialisation of their innovation and/or generate customer data / validate the technology; able to provide evidence to support any assumptions.
According to the current listing, eligibility includes: Businesses developing an innovative product or service in health & life sciences, advanced manufacturing, or creative technologies. Confirm the full requirements in the official notice before applying.
Local Innovation Partnerships Fund (LIPF) is funded by Innovate UK (via West Midlands Combined Authority). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The CFC portal was decommissioned March 4, 2026. No 2026 solicitation period has been announced, no application window opened, and OPM has not said the program is over. Here's what the channel actually was and how to replace it.
Read articleThe Pentagon's APFIT program surpassed $1 billion in awards to small defense innovators, with FY2026 projects averaging $30M each. Paired with SBIR's reauthorization after a five-month shutdown, the defense small business innovation stack has fundamentally changed.
Read articleNew data reveals AI-drafted grant proposals have higher NIH success rates but lower novelty scores. Combined with the six-application annual cap and AI ban, the landscape for researchers is shifting fast.
Read article